New eye injection aims to stop damaging blood vessel growth
NCT ID NCT07329686
Summary
This study is testing a new way to deliver medicine directly into the cornea (the clear front part of the eye) to treat abnormal blood vessel growth caused by herpes eye infections. Researchers want to see if this targeted injection is safe and effective at reducing these blood vessels and improving vision. The trial is recruiting 100 adults who have this specific condition and have not had other similar treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES SIMPLEX KERATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
1 Xihu Avenue, Shangcheng District,Hangzhou, Zhejiang,China,Hangzhou, Zhejiang Completed
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.